Li Mao Selected Research

GQ-ODN T40231

2/2006

Targeting signal transducer and activator of transcription 3 with G-quartet oligonucleotides: a potential novel therapy for head and neck cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Li Mao Research Topics

Disease

76	Neoplasms (Cancer) 02/2022 - 05/2002
35	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2021 - 05/2002
21	Carcinogenesis 01/2021 - 01/2002
19	Lung Neoplasms (Lung Cancer) 01/2021 - 09/2002
15	Squamous Cell Carcinoma of Head and Neck 05/2015 - 01/2002
12	Infections 11/2022 - 01/2018
12	Mouth Neoplasms (Oral Cancer) 01/2018 - 12/2003
9	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2002
9	Inflammation (Inflammations) 01/2022 - 04/2006
6	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 08/2005
6	Head and Neck Neoplasms (Head and Neck Cancer) 11/2015 - 01/2002
5	Disease Progression 01/2021 - 04/2010
5	Adenocarcinoma of Lung 01/2020 - 09/2002
5	Breast Neoplasms (Breast Cancer) 12/2018 - 02/2006
5	Carcinoma (Carcinomatosis) 04/2010 - 11/2002
4	Vitamin D Deficiency 01/2022 - 01/2014
4	Insulin Resistance 01/2022 - 09/2017
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 01/2014
4	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2020
4	Virus Diseases (Viral Diseases) 03/2021 - 10/2018
4	Adenocarcinoma 01/2021 - 04/2006
3	Paramyxoviridae Infections (Parainfluenza) 11/2022 - 09/2020
3	Hepatocellular Carcinoma (Hepatoma) 02/2022 - 01/2020
3	Fatigue 05/2020 - 08/2010
3	Osteonecrosis (Kienbock's Disease) 01/2017 - 03/2015
3	Oral Leukoplakia 01/2013 - 03/2004
2	Fibrosis (Cirrhosis) 01/2022 - 06/2021
2	Glucose Intolerance 01/2022 - 11/2021
2	Type 2 Diabetes Mellitus (MODY) 07/2021 - 01/2019
2	Body Weight (Weight, Body) 07/2021 - 06/2006
2	Hepatolenticular Degeneration (Wilson's Disease) 01/2021 - 01/2020
2	Reperfusion Injury 01/2021 - 11/2017
2	Proteinuria 05/2020 - 01/2014
2	Exanthema (Rash) 01/2020 - 02/2016
2	Hypertension (High Blood Pressure) 01/2020 - 04/2014
2	Esophageal Neoplasms (Esophageal Cancer) 07/2018 - 07/2012
2	Ovarian Neoplasms (Ovarian Cancer) 07/2018 - 10/2003

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
23	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2002
12	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2003
12	Biological ProductsIBA 05/2019 - 10/2002
9	ErbB Receptors (EGF Receptor)IBA 01/2021 - 06/2007
9	Messenger RNA (mRNA)IBA 05/2017 - 09/2002
8	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2017
8	ensartinibIBA 11/2021 - 01/2020
7	Pharmaceutical PreparationsIBA 07/2021 - 12/2003
6	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2017
5	Insulin (Novolin)FDA Link 01/2022 - 07/2017
5	Tyrosine Kinase InhibitorsIBA 11/2021 - 06/2009
5	Indicators and Reagents (Reagents)IBA 01/2013 - 11/2002
4	Vitamin D FDA LinkGeneric 01/2022 - 01/2014
4	Anaplastic Lymphoma KinaseIBA 11/2021 - 01/2020
4	CrizotinibIBA 11/2021 - 01/2018
4	Interleukin-6 (Interleukin 6)IBA 05/2017 - 08/2010
4	ZincIBA 12/2016 - 01/2012
4	ProteomeIBA 02/2016 - 09/2013
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 11/2021
3	Phosphopyruvate Hydratase (Enolase)IBA 01/2022 - 01/2002
3	CopperIBA 01/2021 - 12/2016
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2011
3	Long Noncoding RNAIBA 07/2018 - 10/2015
3	Piwi-Interacting RNAIBA 03/2017 - 08/2013
3	Enhancer of Zeste Homolog 2 ProteinIBA 01/2017 - 11/2011
3	LigandsIBA 04/2015 - 12/2004
3	SmokeIBA 01/2013 - 07/2008
3	Phosphotransferases (Kinase)IBA 11/2012 - 06/2009
3	Small Interfering RNA (siRNA)IBA 06/2012 - 01/2006
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2012 - 10/2003
3	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2010 - 10/2003
3	hepatoma-derived growth factorIBA 05/2009 - 08/2004
3	Death-Associated Protein KinasesIBA 12/2004 - 01/2002
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2018
2	AntibodiesIBA 05/2022 - 05/2009
2	Competitive Endogenous RNAIBA 01/2022 - 01/2020
2	EnzymesIBA 01/2022 - 10/2003
2	Circular RNAIBA 01/2022 - 01/2020
2	Calcitriol (Calcijex)FDA LinkGeneric 01/2022 - 01/2014
2	Blood Glucose (Blood Sugar)IBA 07/2021 - 01/2019
2	oxymatrineIBA 07/2021 - 01/2019
2	InterferonsIBA 03/2021 - 02/2020
2	Monoclonal AntibodiesIBA 03/2021 - 05/2009
2	vorolanibIBA 02/2021 - 05/2020
2	icotinibIBA 01/2021 - 01/2020
2	Penicillamine (Cuprimine)FDA Link 01/2021 - 01/2020
2	PolyphenolsIBA 11/2020 - 05/2017
2	Viral ProteinsIBA 09/2020 - 01/2020
2	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2020 - 02/2016
2	CarbonIBA 11/2019 - 12/2018
2	CytokinesIBA 06/2019 - 08/2010
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 04/2014
2	hydroxide ionIBA 09/2017 - 01/2014
2	Small Untranslated RNAIBA 03/2017 - 06/2015

Therapy/Procedure

19	Therapeutics 02/2022 - 02/2006
11	Drug Therapy (Chemotherapy) 01/2022 - 04/2004
9	Chemoprevention 01/2018 - 01/2002
6	Radiotherapy 01/2011 - 11/2002
3	Immunotherapy 02/2022 - 01/2011
2	Lasers (Laser) 09/2020 - 11/2003
2	Aftercare (After-Treatment) 09/2017 - 01/2015